MKI67 and neoplasm: We observed that tamoxifen treatment decreases the proliferation marker Ki67 and tumor growth in both PDX models and SFX-01 reduced tumor growth in the HBCx34 model, but had no significant impact on BB3RC31 (Figs. 2b and S2a).